New Developments

New treatment for Uveal Melanoma

A new procedure has been developed at the European CyberKnife Centre in Munich (ECZM) which avoids the need for this drastic step and MHL is now able to introduce patients from around the world.

Zurich cancer centre offers new breast cancer treatment

Advanced treatment centres

Non-invasive medical technologies

Private medical centres

Klinik Hirslanden in Zurich is the principal hospital of Switzerland's largest private healthcare group. As Switzerland's premier cancer centre it is one of only a handful in Europe to offer intraoperative radiotherapy. By applying radiation directly to the tumour bed as part of a lumpectomy operation, this can spare breast cancer patients from weeks of conventional radiotherapy with risk of radiation burn to the skin .

Klinik Hirslanden also offers a full range of medical and surgical services including the latest high-technology treatment devices including CyberKnife® radiosurgery Trilogy® 'stereotactic', image guided radiotherapy, da Vinci® robotic surgery, and advanced cardiac facilities.

Uveal melanoma is a cancer of the eye. A variety of treatments is available but in severe cases complete removal of the eye can be required.

The Hirslanden Neuropelveology Centre in Zurich, Switzerland, offers new hope to patients with chronic abdominal pain, sciatica, phantom pain, multiple sclerosis, extensive endometriosis and bladder and bowel dysfunction. Details in our MHL Clinics web site.

Prof Marc Possover, Medical Director, is recognised worldwide as a leader in laparoscopic surgery of the nerves located in the small pelvis.

Pioneering Neuropelveology Centre

HCG Oncology joins our global CyberKnife^® enquiry service

In August 2010 we welcomed HCG Oncology, South Asia's largest cancer care provider, with centres across India and in neighbouring countries.

MHL expansion to South America and new holiday dialysis centres

Their CyberKnife radiosurgery centre in Bangalore joined our global enquiry service giving patients and doctors a choice of four centres to apply to. HCG also offers a wide range of cancer therapies including image guided radiotherapy and medical oncology.

Also in August 2010 we added new web sites for Mexico, Brazil and Argentina to help patients in South America to gain access to leading international treatment centres.

New dialysis centres in Greece and Italy were added to our web site MHL Dialysis, which offer assistance with hotels and travel arrangements for dialysis patients seeking a holiday in locations including Santorini, Pompei and Sorrento.

In October 2010 UKE in Hamburg, Germany, enrolled in our patient and doctor enquiry service and we have initially selected two key specialities for presentation to international patients.

The Martini Prostate Clinic at UKE offers a range of treatments including 'robotic' surgery. 95% of Martini Klinik patients are fully continent after nerve-preserving surgery.

UKE (University Hospital) Hamburg joins MHL

The UKE Voice Clinic diagnoses and treats voice, speech and hearing difficulties. The Clinic is led by Dr Markus Hess, a recognized expert on care of the professional voice and phonosurgery.

Centre Léon-Bérard joins our CyberKnife^® referral service

In March 2011 Centre Léon-Bérard in Lyon, France became the fifth centre to join our CyberKnife referral service.

Centre Léon-Bérard is a private, non-profit, hospital dedicated to cancer treatment and research and is also one of the largest paediatric oncology centres in France.

This centre has the latest CyberKnife VSI system, which is particularly advantageous for treatment of soft tissue tumours. It also has a range of the latest radio-oncology treatment devices and has become a leader in its field and a reference centre for the Rhone-Alpes region of France.

Rinecker proton and surgery centre, Munich, Germany

Rinecker Proton Therapy Centre joins MHL

In April 2011 we added our first proton therapy centre. Rinecker Proton Therapy Centre is a dedicated, purpose-built €150m private cancer centre in Munich, Germany, complete with guest services on site.

Proton therapy treats any condition which can be treated with radiotherapy, but it offers many important advantages. X-ray beams penetrate through the tumour into sound tissue beyond, but proton beams stop at the precise depth required.

This means that proton therapy can safely deliver high doses of radiation to the target tumour in shorter times, whilst sparing nearby sensitive organs and greatly reducing side effects.

MHL international web sites

MHLhealth.com

Web sites in 30 countries

Click map for details